Literature DB >> 16333182

Botulinum toxin in ophthalmic plastic surgery.

Milind N Naik1, Charles Ns Soparkar, R Murthy, S G Honavar.   

Abstract

Botulinum toxin chemodenervation has evolved greatly over the past 30 years since its introduction in the 1970s for the management of strabismus. Among ophthalmic plastic surgeons, botulinum toxins are often used as the first line treatment for facial dystonias. These toxins are also efficacious for the temporary management of various other conditions including keratopathies (through so called chemo-tarsorraphy), upper eyelid retraction, orbicularis overaction-induced lower eyelid entropion, gustatory epiphora, Frey's syndrome, and dynamic facial rhytids such as lateral canthal wrinkles (crow's feet), glabellar creases and horizontal forehead lines. This article describes the pharmacology, reconstitution techniques and common current applications of botulinum toxins in ophthalmic plastic surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333182     DOI: 10.4103/0301-4738.18915

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  6 in total

Review 1.  A review on use of botulinum toxin for intractable lacrimal drainage disorders.

Authors:  Swati Singh; Mohammad Javed Ali; Friedrich Paulsen
Journal:  Int Ophthalmol       Date:  2017-08-01       Impact factor: 2.031

2.  Noncosmetic periocular therapeutic applications of botulinum toxin.

Authors:  Pelin Kaynak-Hekimhan
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

3.  Comparison Between Botulinum Toxin A Injection and Lacrimal Punctal Plugs for the Control of Post-LASIK Dry Eye Manifestations: A Prospective Study.

Authors:  Sameh M Fouda; Hala K Mattout
Journal:  Ophthalmol Ther       Date:  2017-02-02

4.  Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection.

Authors:  Purvasha Narang; Swati Singh; Vikas Mittal
Journal:  Indian J Ophthalmol       Date:  2018-05       Impact factor: 1.848

5.  Botulinum toxin A for the treatment of first bite syndrome.

Authors:  Dmitry Tretiakow; Katarzyna Lammek; Andrzej Skorek
Journal:  Gland Surg       Date:  2022-07

6.  Transconjunctival botulinum toxin injection into the lacrimal gland in crocodile tears syndrome.

Authors:  Sabyasachi Pattanayak; Pramod Kumar Sharma; Swati Samikhya; Ipsita Khuntia; Kalyani Patra
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.